BCTX (BriaCell Therapeutics) Prakiraan rega marang bathi

The forward P/E ratio of BriaCell Therapeutics (BCTX) reflects the dynamics of a company developing immuno-oncology through partnerships with pharma giants to create therapeutic synergy. The value of 0.00 represents the current level of this metric, while the binary risks of a narrow pipeline are mitigated by accelerated approvals from US regulators. Growth potential is driven by proprietary vaccines, which enable the business to scale across the global market following clinical trials.

Rasio prakiraan rega marang bathi: BriaCell (BCTX) kanggo 04.07.2022 - 14.11.2026

Ringkesan rincian data analitis briacell.com (BCTX)

- rega saiki lan proyeksi nilai saham:

Kutipan saham BriaCell Therapeutics Corp|BCTX - Konsensus nilai wajar

- indikator valuasi pasar bisnis:

Biji pasar BriaCell|BCTX - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- statistik nilai buku emiten:

Aset Bersih saben Siji Saham BriaCell|BCTX - Ekuitas Perusahaan|Rasio Nilai Pasar marang Nilai Buku briacell.com|BCTX - Gunggung Aset Perusahaan

- indikator beban kredit lan likuiditas emiten:

Total Utang marang Modal BriaCell Therapeutics|BCTX - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas BriaCell Therapeutics Corp|BCTX - Utang agregat perusahaan|Utang-utang marang kapitalisasi buku BriaCell Corp|BCTX - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan BriaCell|Rasio cepet briacell.com

- indikator profitabilitas perusahaan lan kelipatan valuasi:

BCTX - Asil keuangan resik|Proyeksi bathi mangsa ngarep BriaCell Therapeutics|BCTX - Pangali P/E|Pangali Forward P/E briacell.com|BCTX - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA BriaCell Therapeutics Corp.|BCTX - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan BriaCell|BCTX - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan briacell.com|BCTX - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep BriaCell Therapeutics

- data dodolan lan asil:

BCTX - Pendapatan dodolan perusahaan|Volume dodolan mangsa ngarep perusahaan BriaCell|BCTX - Kapitalisasi marang volume dodolan|Multiplikator Forward P/S BriaCell

Ringkesan analitik perusahaan:BriaCell Therapeutics Corp

This indicator assesses the market value of the business relative to expected net income one year from now, allowing for a determination of the premium paid for future earnings. By analyzing the forward P/E ratio of BriaCell Therapeutics (BCTX), an investor can weigh the market's speculative optimism against the commercialization potential of personalized vaccines within the advanced breast cancer therapy segment.

Perusahaan pesaing

Prakiraan rega marang bathi MRUS (Merus Corp)|IMMP (Immutep Limited) - Pangali mangsa ngarep rega marang bathi|anixa.com - Prakiraan rega marang bathi|ATOS - Prakiraan rega marang bathi|CNTX - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi Mersana Therapeutics, Inc.|ESSA Pharma Inc (EPIX) - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi QT Imaging, Inc. (QTI)